Glucomannan for abdominal pain-related functional gastrointestinal disorders in children: A randomized trial

Table 1 Study population baseline characteristics n (%)

	Placebo	Glucomannan
Patients recruited	45	44
Male/female	21/22	21/20
Age mean, yr	11.3 ± 2.5	11.6 ± 3.0
Self-reported frequency of pain1
Pain 1-3 times per month
Pain 1-2 times per week	12 (27.9)	9 (21.9)
Pain > 2 times per week	13 (30.2)	9 (21.9)
Pain every day	14 (32.6)	14 (34.1)
	4 (9.3)	9 (21.9)
Severity of pain1
“face 0”	0 (0)	0 (0)
“face 1”	5 (11.6)	2 (4.8)
“face 2”	18 (40.8)	13 (31.7)
“face 3”	15 (34.8)	16 (39.0)
“face 4”	5 (11.6)	8 (19.5)
“face 5”	0 (0)	2 (4.8)
Self-reported absenteeism from school	21	21
Self-reported alterations in daily activities	29	27
Number of subjects who required rescue therapy	20	25

¹Wilcoxon’s test.